IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Healthcare Value Capital, LLC

Q4 2019 Holdings

Filed 2020-02-14 | 16 holdings | $4.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Abbvie Inc(ABBV)COM00287Y109$4.4M50,00099.3%
Glaxosmithkline PLCSPONSORED ADR37733W105$4.7K100,0000.1%
Gilead Sciences Inc(GILD)COM375558103$4.5K70,0000.1%
CVS Health Corp(CVS)COM126650100$3.7K50,0000.1%
Tyme Technologies IncCOM90238J103$3.0K2,175,0000.1%
Viking Therapeutics Inc(VKTX)COM92686J106$2.0K250,0000.0%
Cardinal Health Inc(CAH)COM14149Y108$1.8K35,0000.0%
Amerisourcebergen Corp(COR)COM03073E105$1.7K20,0000.0%
Clovis Oncology Inc(CLVSEUR)COM189464100$1.6K150,0000.0%
Antares Pharma Inc(ATRSEUR)COM036642106$1.4K300,0000.0%
Mckesson Corp(MCK)COM58155Q103$1.4K10,0000.0%
Foamix Pharmaceuticals LTDSHSM46135105$1.2K350,0000.0%
Clovis Oncology Inc(CLVSEUR)CallCOM189464100$1.0K100,0000.0%
Adamas Pharmaceuticals Inc(ADMSEUR)CallCOM00548A106$758200,0000.0%
Greenlane Hldgs IncCL A395330103$570175,0000.0%
Foamix Pharmaceuticals LTDCallSHSM46135105$16750,0000.0%